Competition Commission of India okays Bayer-Monsanto merger but with riders

It said the merged entity will follow a policy of non-exclusive licensing of non-selective herbicides or their active ingredient(s)

The firms are in a race to create new clubroot-resistant seeds, but all three firms say that the process takes most of a decade - and any solution may not last long because the clubroot pathogen quickly adapts.
The firms are in a race to create new clubroot-resistant seeds, but all three firms say that the process takes most of a decade — and any solution may not last long because the clubroot pathogen quickly adapts.
Sanjeeb Mukherjee New Delhi
Last Updated : Jun 21 2018 | 7:04 AM IST
The merged Bayer-Monsanto entity in India will need to give non-exclusive licensing of its genetically modified (GM) and non-GM traits, currently commercialised in India or to be introduced in the near future on a fair, reasonable and non-discriminatory basis, the Competition Commission of India (CCI) has said.

Approving the merger of Bayer and Monsanto in India, the CCI released conditions attached with the approval.

It said the merged entity will follow a policy of non-exclusive licensing of non-selective herbicides or their active ingredient(s). 

It will be in the case of launch of new GM or non-GM traits in India that restrict agricultural producers, including farmers, from using specific non-selective herbicide(s) being supplied only by the parties, on a fair, reasonable and non-discriminatory basis.

The merged entity will also grant access to Indian agro-climatic data, free of charge, to the central government and its institutions, to be used exclusively for public good, the CCI said.

Read more: Bayer begins process to buy up to 26% stake in Monsanto for over Rs 13 bn
 
The CCI order also said that the combined entity is also barred from offering its clients, farmers, distribution channels or its commercial partners, two or more products as a bundle as this may potentially have the effect of exclusion of any competitor.

The commission asked Bayer to divest its glufosinate ammonium (a non-selective herbicide), crop traits of cotton and corn, and hybrid seeds of its vegetables businesses.

It also ordered that Monsanto should divest shareholding in Maharashtra Hybrid Seed Company Limited (26 per cent) to an independent entity. Bayer is also supposed to honour these changes for seven years from culmination of the deal.

CCI’s approval of the $66 billion deal, proposed in September 2016, will make the merged entity the world’s largest seed and pesticide player. 

Read more: EU says Bayer Monsanto must not hurt competition in digital farming

Russia, China and European Union have already approved their merger.

EU has stipulated, among other conditions, Bayer will have to exit global field crop seeds businesses such as canola, cotton, and soybean, R&D platform for hybrid wheat, global vegetable seeds business, global glufosinate ammonium business as well as certain glyphosate-based herbicides business in Europe.

Russia’s Federal Anti-monopoly Service (FAS) has also given approval on the condition that Russia be provided modern technologies from Bayer and Monsanto. 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story